Therapeutic options for chronic prostatitis/chronic pelvic pain syndrome

被引：11

作者：

Potts J.M. ^{[1
]}

机构：

[1] Glickman Urological Institute, 9500 Euclid Avenue, A/100, Cleveland, 44195, OH

来源：

Current Urology Reports | 2005年 / 6卷 / 4期

关键词：

Benign Prostatic Hyperplasia; Finasteride; International Prostate Symptom Score; Lower Urinary Tract Symptom; Prostatitis;

D O I：

10.1007/s11934-005-0030-5

中图分类号：

学科分类号：

摘要：

Chronic prostatitis/chronic pelvic pain syndrome continues to pose a treatment challenge for urologists. Most commonly prescribed medications, such as antibiotics, α-blockers, androgen inhibitors, and anti-inflammatory agents, have been shown to help some patients. However, the efficacy and durability of such treatments lack consistency among men suffering from this disorder. The rationale for such treatments is described in this article, along with possible explanations for the apparent shortcomings. Also included is a brief summary of alternative therapies, which are growing in popularity among patients and gaining acceptance in our medical communities. © 2005, Current Science Inc.

引用

页码：313 / 317

页数：4

共 25 条

[1]

Turner J.A., Ciol M.A., Von Korff M., Et al., Healthcare use and costs of primary and secondary care patients with prostatitis, Urology, 63, pp. 1031-1035, (2004)

[2]

Nickel J.C., Recommendations for the evaluation of patients with prostatitis, World J Urol, 21, pp. 75-81, (2003)

[3]

Nickel J.C., Downey J., Ardern D., Failure of a monotherapy strategy for difficult chronic prostatitis/chronic pelvic pain syndrome, J Urol, 172, pp. 551-554, (2004)

[4]

Shoskes D.A., Thomas K., Gomez E., Antinanobacterial therapy in men with chronic prostatitis/chronic pelvic pain syndrome and prostatic stones: Preliminary experience, J Urol

[5]

Nickel J.C., Alexander R.B., Schaeffer A.J., Et al., Bacteria localizator does not correlate to symptoms and localization prevalence in indisting work in CP/CPPS versus controls, J Urol, (2003)

[6]

Nickel J.C., Downey J., Clark J., Et al., Levofloxacin for chronic prostatitis/chronic pelvic pain syndrome in men: a randomized, placebo-controlled, multicenter trail, Urology, 62, pp. 614-617, (2003)

[7]

Alexander R.B., Propert K.J., Schaeffer A.J., Et al., Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome, Ann Intern Med, 141, pp. 581-589, (2004)

[8]

Wagenlehner F.M., Naber K.G., Antimicrobial treatment of prostatitis, Expert Rev Anti Infect Ther, 1, pp. 275-282, (2003)

[9]

Evliyaoglu Y., Burgut R., Lower urinary tract symptoms, pain, and quality-of-life assessment in chronic non-bacterial prostatitis patients treated with a-blocking agent doxazosin versus placebo, Int Urol Nephrol, 34, pp. 351-356, (2002)

[10]

Gul O., Eroglu M., Ozok U., Use of terazosin in patients with chronic pelvic pain syndrome and evaluation by prostatitis symptom score index, Int Urol Nephrol, 32, pp. 433-436, (2001)

← 1 2 3 →